Sanofi Pasteur and Merck Vaccines Appoint David Khougazian as President of Sanofi Pasteur MSD

LYON, France, June 29, 2015 /PRNewswire/ --

MSD, known as Merck in the United States and Canada (NYSE: MRK) and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), the two partner companies in Sanofi Pasteur MSD, announce today the appointment of David Khougazian as president of Sanofi Pasteur MSD.

To view the Multimedia News Release, please click:   http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur/

On July 1, Khougazian will join Sanofi Pasteur MSD and effective September 1, will succeed Dr. Jean-Paul Kress, who led the company since July 2011. Kress will leave Sanofi Pasteur MSD to join the Sanofi group.

Video: 
     http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur/